BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $98,227 | -4.3% | 100,000 | 0.0% | 0.00% | – |
| Q1 2023 | $102,598 | -3.3% | 100,000 | 0.0% | 0.00% | – |
| Q4 2022 | $106,130 | +7.2% | 100,000 | 0.0% | 0.00% | – |
| Q3 2022 | $99,000 | 0.0% | 100,000 | 0.0% | 0.00% | – |
| Q2 2022 | $99,000 | -1.0% | 100,000 | 0.0% | 0.00% | – |
| Q1 2022 | $100,000 | -67.9% | 100,000 | -66.4% | 0.00% | -100.0% |
| Q4 2021 | $312,000 | -40.0% | 298,000 | -41.3% | 0.00% | 0.0% |
| Q3 2021 | $520,000 | -18.2% | 508,000 | -17.3% | 0.00% | 0.0% |
| Q2 2021 | $636,000 | -31.4% | 614,000 | -33.0% | 0.00% | -50.0% |
| Q1 2021 | $927,000 | +33.6% | 916,000 | +41.6% | 0.00% | 0.0% |
| Q4 2020 | $694,000 | +46.7% | 647,000 | +43.5% | 0.00% | +100.0% |
| Q3 2020 | $473,000 | +15.9% | 451,000 | +35.0% | 0.00% | 0.0% |
| Q2 2020 | $408,000 | +16.6% | 334,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $350,000 | -34.5% | 334,000 | -33.9% | 0.00% | -50.0% |
| Q4 2019 | $534,000 | +7.7% | 505,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $496,000 | -5.3% | 505,000 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $524,000 | +1.4% | 505,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $517,000 | – | 505,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,298,000 | $15,340,000 | 1.64% |
| ZAZOVE ASSOCIATES LLC | 25,540,000 | $24,103,000 | 1.55% |
| PIER 88 INVESTMENT PARTNERS LLC | 3,030,000 | $2,844,000 | 1.36% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,184,000 | 1.12% |
| Sonora Investment Management, LLC | 7,100,000 | $6,681,214,000 | 1.06% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 43,256,000 | $40,793,000 | 0.80% |
| Opera Trading Capital | 10,000,000 | $9,370,000 | 0.72% |
| AQR Arbitrage LLC | 52,575,000 | $49,486,000 | 0.57% |
| Neuberger Berman Group LLC | 5,000,000 | $469,375,000 | 0.54% |
| CQS Cayman LP | 12,000,000 | $11,322,000 | 0.52% |